Bernhard Klumpp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bernhard Klumpp has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Ulrich Kramer
Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany
7 shared publications - Claus Detlef Claussen
Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany
6 shared publications Stephan Miller
Radiologiepraxis Tuebingen, Radiologiepraxis Tuebingen, Germany
5 shared publications- Konstantin Nikolaou
Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany
4 shared publications - Meinrad Gawaz
Department of Cardiology and Angiology, University Hospital Tübingen, University Tübingen, Tübingen, Germany
4 shared publications - Michael Fenchel
Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany
4 shared publications
Latest Publications
- 1 January 2018
- Published by Springer Nature
- p. 35-42
Bildgebende Diagnostik bei Tumoren des Peritoneums
- 1 January 2018
- Published by Springer Nature
- p. 35-42
Bildgebende Diagnostik bei Tumoren des Peritoneums
- Open Access
- 3 November 2017
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 190 (01) , 42-50
Impact of Papillary Muscle Infarction on Ischemic Mitral Regurgitation Assessed by Magnetic Resonance Imaging
Objective Ischemic mitral regurgitation is a predictor of heart failure resulting in increased mortality in patients with chronic myocardial infarction. It is uncertain whether the presence of papillary muscle (PM) infarction contributes to the development of mitral regurgitation in patients with chronic myocardial infarction (MI). The aim of the present study was to assess the correlation of PM infarction depicted by MRI with mitral regurgitation and left ventricular function. Methods and Materials 48 patients with chronic MI and recent MRI and echocardiography were retrospectively included. The location and extent of MI depicted by MRI were correlated with left ventricular function assessed by MRI and mitral regurgitation assessed by echocardiography. The presence, location and extent of PM infarction depicted by late gadolinium enhancement (LGE-) MRI were correlated with functional parameters and compared with patients with chronic MI but no PM involvement. Results PM infarction was found in 11 of 48 patients (23 %) using LGE-MRI. 8/11 patients (73 %) with PM infarction and 22/37 patients (59 %) without PM involvement in MI had ischemic mitral regurgitation. There was no significant difference between location, extent of MI and presence of mitral regurgitation between patients with and without PM involvement in myocardial infarction. In 4/4 patients with complete and in 4/7 patients with partial PM infarction, mitral regurgitation was present. The normalized mean left ventricular end-diastolic volume was increased in patients with ischemic mitral regurgitation. Conclusion The presence of PM infarction does not correlate with ischemic mitral regurgitation. In patients with complete PM infarction and consequent discontinuity of viable tissue in the PM-chorda-mitral valve complex, the probability of developing ischemic mitral regurgitation seems to be increased. However, the severity of mitral regurgitation is not increased compared to patients with partial or no PM infarction. Key points Citation Format Zielsetzung Die ischämische Mitralinsuffizienz ist ein negativer Prädiktor für eine Herzinsuffizienz und für eine hierdurch bedingte erhöhte Mortalität von Patienten mit chronischem Myokardinfarkt (MI). Ein kausaler Zusammenhang zwischen Papillarmuskelinfarkt (PMI) und ischämisch bedingter Mitralinsuffizienz ist unsicher. Ziel der vorgestellten Studie war es, den Zusammenhang von PMI in der MRT und Mitralinsuffizienz sowie linksventrikulärer Funktion zu untersuchen. Material und Methodik 48 Patienten mit chronischem MI und aktuellem MRT und Echokardiografie wurden retrospektiv eingeschlossen. Lokalisation und Ausmaß des MI in der MRT wurden mit der linksventrikulären Funktion in der MRT und der Mitralinsuffizienz in der Echokardiografie korreliert. Vorhandensein, Lokalisation und Ausmaß eines PMI in der Late-Gadolinium Enhancement (LGE-) MRT wurden mit diesen Funktionsparametern korreliert und mit Patienten mit chronischem MI ohne PMI verglichen. Ergebnisse Bei 11 von 48 Patienten (23 %) konnte mittels LGE-MRT ein PMI nachgewiesen werden. Eine ischämische Mitralinsuffizienz bestand bei 8/11 Patienten mit PMI (73 %) und bei 22/37 Patienten mit MI ohne PMI (59 %). Es ergab sich kein signifikanter Unterschied hinsichtlich Lokalisation und Ausmaß des MI und der Mitralinsuffizienz zwischen Patienten mit und ohne PMI. Bei 4/4 Patienten mit vollständigem und bei 4/7 Patienten mit partiellem PMI bestand eine Mitralinsuffizienz. Das mittlere enddiastolische Volumen war bei Patienten mit Mitralinsuffizienz erhöht. Schlussfolgerung Es ergibt sich kein eindeutiger Zusammenhang zwischen dem Vorhandensein eines PMI und der Entwicklung einer ischämischen Mitralinsuffizienz. Bei Patienten mit vollständigem PMI scheint aufgrund einer Unterbrechung der Kontinuität vitalen Gewebes des Papillarmuskel-Chorda-Mitralklappen Komplex ein erhöhtes Risiko für das Auftreten einer ischämischen Mitralinsuffizienz zu bestehen. Der Schweregrad der Mitralinsuffizienz ist im Vergleich zu Patienten mit partiellem oder ohne PMI nicht erhöht. Kernaussagen
- 3 November 2017
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 190 (01) , 42-50
Open AccessImpact of Papillary Muscle Infarction on Ischemic Mitral Regurgitation Assessed by Magnetic Resonance Imaging
Objective Ischemic mitral regurgitation is a predictor of heart failure resulting in increased mortality in patients with chronic myocardial infarction. It is uncertain whether the presence of papillary muscle (PM) infarction contributes to the development of mitral regurgitation in patients with chronic myocardial infarction (MI). The aim of the present study was to assess the correlation of PM infarction depicted by MRI with mitral regurgitation and left ventricular function. Methods and Materials 48 patients with chronic MI and recent MRI and echocardiography were retrospectively included. The location and extent of MI depicted by MRI were correlated with left ventricular function assessed by MRI and mitral regurgitation assessed by echocardiography. The presence, location and extent of PM infarction depicted by late gadolinium enhancement (LGE-) MRI were correlated with functional parameters and compared with patients with chronic MI but no PM involvement. Results PM infarction was found in 11 of 48 patients (23 %) using LGE-MRI. 8/11 patients (73 %) with PM infarction and 22/37 patients (59 %) without PM involvement in MI had ischemic mitral regurgitation. There was no significant difference between location, extent of MI and presence of mitral regurgitation between patients with and without PM involvement in myocardial infarction. In 4/4 patients with complete and in 4/7 patients with partial PM infarction, mitral regurgitation was present. The normalized mean left ventricular end-diastolic volume was increased in patients with ischemic mitral regurgitation. Conclusion The presence of PM infarction does not correlate with ischemic mitral regurgitation. In patients with complete PM infarction and consequent discontinuity of viable tissue in the PM-chorda-mitral valve complex, the probability of developing ischemic mitral regurgitation seems to be increased. However, the severity of mitral regurgitation is not increased compared to patients with partial or no PM infarction. Key points Citation Format Zielsetzung Die ischämische Mitralinsuffizienz ist ein negativer Prädiktor für eine Herzinsuffizienz und für eine hierdurch bedingte erhöhte Mortalität von Patienten mit chronischem Myokardinfarkt (MI). Ein kausaler Zusammenhang zwischen Papillarmuskelinfarkt (PMI) und ischämisch bedingter Mitralinsuffizienz ist unsicher. Ziel der vorgestellten Studie war es, den Zusammenhang von PMI in der MRT und Mitralinsuffizienz sowie linksventrikulärer Funktion zu untersuchen. Material und Methodik 48 Patienten mit chronischem MI und aktuellem MRT und Echokardiografie wurden retrospektiv eingeschlossen. Lokalisation und Ausmaß des MI in der MRT wurden mit der linksventrikulären Funktion in der MRT und der Mitralinsuffizienz in der Echokardiografie korreliert. Vorhandensein, Lokalisation und Ausmaß eines PMI in der Late-Gadolinium Enhancement (LGE-) MRT wurden mit diesen Funktionsparametern korreliert und mit Patienten mit chronischem MI ohne PMI verglichen. Ergebnisse Bei 11 von 48 Patienten (23 %) konnte mittels LGE-MRT ein PMI nachgewiesen werden. Eine ischämische Mitralinsuffizienz bestand bei 8/11 Patienten mit PMI (73 %) und bei 22/37 Patienten mit MI ohne PMI (59 %). Es ergab sich kein signifikanter Unterschied hinsichtlich Lokalisation und Ausmaß des MI und der Mitralinsuffizienz zwischen Patienten mit und ohne PMI. Bei 4/4 Patienten mit vollständigem und bei 4/7 Patienten mit partiellem PMI bestand eine Mitralinsuffizienz. Das mittlere enddiastolische Volumen war bei Patienten mit Mitralinsuffizienz erhöht. Schlussfolgerung Es ergibt sich kein eindeutiger Zusammenhang zwischen dem Vorhandensein eines PMI und der Entwicklung einer ischämischen Mitralinsuffizienz. Bei Patienten mit vollständigem PMI scheint aufgrund einer Unterbrechung der Kontinuität vitalen Gewebes des Papillarmuskel-Chorda-Mitralklappen Komplex ein erhöhtes Risiko für das Auftreten einer ischämischen Mitralinsuffizienz zu bestehen. Der Schweregrad der Mitralinsuffizienz ist im Vergleich zu Patienten mit partiellem oder ohne PMI nicht erhöht. Kernaussagen
- Open Access
- 1 July 2017
- Published by Springer Nature in Cancer Imaging
- Vol. 17 (1) , 1-8
Imaging characteristics of cardiac metastases in patients with malignant melanoma
Due to prolonged survival and technical advances in CT imaging, cardiac metastases in patients with malignant melanoma are observed more frequently nowadays. The aim of the present study was to assess the anatomic distribution as well as the morphologic and histologic appearance of cardiac metastases from malignant melanoma. Twenty five patients with known metastasized melanoma and with incidental finding of cardiac metastases during routine staging CT were retrospectively included in this study. CT images were assessed for the presence, localization and extent of cardiac metastases. Histological results, mutational analysis and tumor markers were reviewed. Fourteen out of 25 patients presented with singular cardiac mass (56%), whereas ten patients (40%) presented with multifocal and one patient with disseminated cardiac metastases. Twelve patients presented with endocardial (48%), eight with myocardial and two with pericardial metastases. Most frequent site involved in endocardial metastases was the right atrium (67%) followed by the right ventricle (33%). There seems to be a correlation between histological subtype and location of cardiac metastasis. Median survival after diagnosis of cardiac metastases was 8 months, with no significant difference regarding the localization of metastases within the heart. Cardiac metastases can involve every part of the heart possibly in dependence of histological subtype. The awareness of different types of cardiac metastases and their characteristic appearance on CT images is necessary for further investigations and might contribute to targeted therapy.
- 1 July 2017
- Published by Springer Nature in Cancer Imaging
- Vol. 17 (1) , 1-8
Open AccessImaging characteristics of cardiac metastases in patients with malignant melanoma
Due to prolonged survival and technical advances in CT imaging, cardiac metastases in patients with malignant melanoma are observed more frequently nowadays. The aim of the present study was to assess the anatomic distribution as well as the morphologic and histologic appearance of cardiac metastases from malignant melanoma. Twenty five patients with known metastasized melanoma and with incidental finding of cardiac metastases during routine staging CT were retrospectively included in this study. CT images were assessed for the presence, localization and extent of cardiac metastases. Histological results, mutational analysis and tumor markers were reviewed. Fourteen out of 25 patients presented with singular cardiac mass (56%), whereas ten patients (40%) presented with multifocal and one patient with disseminated cardiac metastases. Twelve patients presented with endocardial (48%), eight with myocardial and two with pericardial metastases. Most frequent site involved in endocardial metastases was the right atrium (67%) followed by the right ventricle (33%). There seems to be a correlation between histological subtype and location of cardiac metastasis. Median survival after diagnosis of cardiac metastases was 8 months, with no significant difference regarding the localization of metastases within the heart. Cardiac metastases can involve every part of the heart possibly in dependence of histological subtype. The awareness of different types of cardiac metastases and their characteristic appearance on CT images is necessary for further investigations and might contribute to targeted therapy.
- 26 April 2017
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 189 (06) , 549-551
ALADAPA-Syndrom (Anomalous Origin of the Left Anterior Descending Artery from the Pulmonary Artery) – Ein seltener CT-Befund nach unklarer Koronarangiografie
Kongenitale Koronaranomalien treten mit einer Inzidenz von ca. 0,5 – 1 % auf und werden in 15 – 60 % der Fälle als Ursache eines plötzlichen Herztodes angesehen (Green MS et al. Semin Cardiothorac Vasc Anesth 2016; 20: 232 – 236). Von Bedeutung ist hierbei sowohl die Lokalisation des varianten Abgangs der Koronararterien aus der Aorta als auch der daraus resultierende aberrante Verlauf. Dieser spielt insbesondere dann eine Rolle, wenn der Koronarabgang auf der Gegenseite zur anatomischen Norm liegt. Der Häufigkeit nach werden folgende Anomalien unterschieden: Ein Abgang der rechten Koronararterie (RCA) vom linken Sinus Valsalvae; ein Abgang der linken Koronararterie (LMCA) vom rechten Sinus valsalvae und ein separater Abgang des Ramus circumflexus (LCX) oder des Ramus interventricularis anterior (LAD) vom rechten Sinus valsalvae (Kim SY et al. Radiographics 2006; 26: 317 – 334). Für den Gefäßverlauf zur Gegenseite werden typischerweise folgende Varianten beobachtet: 1) retroaortal – zwischen Aorta und linkem Vorhof; 2) interarteriell – zwischen Aorta und Truncus pulmonalis (auch als maligne Form bezeichnet, da als eigenständiger Risikofaktor für plötzlichen Herztod angesehen); 3) prätrunkal – ventral des Truncus pulmonalis und 4) interseptal/transmural – durch das Septum ziehend (Villa AD et al. World J Radiol 2016; 8: 537 – 555). Eine wesentlich seltenere Anomalie als die oben genannten atypischen Koronararterienabgänge aus der Aorta stellen Fehlabgänge der (linken) Koronararterie aus dem Truncus pulmonalis dar (ALCAPA-Syndrom – Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery), auch bekannt unter dem Eponym Bland-White-Garland-Syndrom. Die Inzidenz dieser Anomalie wird mit ≤ 0,5 % aller kongenitalen Herzfehler angegeben (Lopes R et al. Congenit Heart Dis 2011; 6: 366 – 369). Noch weitaus seltener als das klassische ALCAPA-Syndrom ist der isolierte aberrante Abgang der LAD aus dem Truncus pulmonalis, auch als ALADAPA-Syndrom bezeichnet (Anomalous Origin of the Left Anterior Descending Artery from the Pulmonary Artery) (Murat G et al. Interact Cardiovasc Thorac Surg 2015; 20: 283 – 284), wie in folgendem Fall dargestellt.
- 26 April 2017
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 189 (06) , 549-551
ALADAPA-Syndrom (Anomalous Origin of the Left Anterior Descending Artery from the Pulmonary Artery) – Ein seltener CT-Befund nach unklarer Koronarangiografie
Kongenitale Koronaranomalien treten mit einer Inzidenz von ca. 0,5 – 1 % auf und werden in 15 – 60 % der Fälle als Ursache eines plötzlichen Herztodes angesehen (Green MS et al. Semin Cardiothorac Vasc Anesth 2016; 20: 232 – 236). Von Bedeutung ist hierbei sowohl die Lokalisation des varianten Abgangs der Koronararterien aus der Aorta als auch der daraus resultierende aberrante Verlauf. Dieser spielt insbesondere dann eine Rolle, wenn der Koronarabgang auf der Gegenseite zur anatomischen Norm liegt. Der Häufigkeit nach werden folgende Anomalien unterschieden: Ein Abgang der rechten Koronararterie (RCA) vom linken Sinus Valsalvae; ein Abgang der linken Koronararterie (LMCA) vom rechten Sinus valsalvae und ein separater Abgang des Ramus circumflexus (LCX) oder des Ramus interventricularis anterior (LAD) vom rechten Sinus valsalvae (Kim SY et al. Radiographics 2006; 26: 317 – 334). Für den Gefäßverlauf zur Gegenseite werden typischerweise folgende Varianten beobachtet: 1) retroaortal – zwischen Aorta und linkem Vorhof; 2) interarteriell – zwischen Aorta und Truncus pulmonalis (auch als maligne Form bezeichnet, da als eigenständiger Risikofaktor für plötzlichen Herztod angesehen); 3) prätrunkal – ventral des Truncus pulmonalis und 4) interseptal/transmural – durch das Septum ziehend (Villa AD et al. World J Radiol 2016; 8: 537 – 555). Eine wesentlich seltenere Anomalie als die oben genannten atypischen Koronararterienabgänge aus der Aorta stellen Fehlabgänge der (linken) Koronararterie aus dem Truncus pulmonalis dar (ALCAPA-Syndrom – Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery), auch bekannt unter dem Eponym Bland-White-Garland-Syndrom. Die Inzidenz dieser Anomalie wird mit ≤ 0,5 % aller kongenitalen Herzfehler angegeben (Lopes R et al. Congenit Heart Dis 2011; 6: 366 – 369). Noch weitaus seltener als das klassische ALCAPA-Syndrom ist der isolierte aberrante Abgang der LAD aus dem Truncus pulmonalis, auch als ALADAPA-Syndrom bezeichnet (Anomalous Origin of the Left Anterior Descending Artery from the Pulmonary Artery) (Murat G et al. Interact Cardiovasc Thorac Surg 2015; 20: 283 – 284), wie in folgendem Fall dargestellt.
- Open Access
- 15 July 2016
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 1-9
Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT
Anorectal malignant melanomas (ARMM) are rare tumors, characterized by an early lymphatic spread and distant metastasis, resulting in an extremely poor overall survival. The objective of this study was to determine the pattern of regional lymph node metastasis (LNM) by computed tomography (CT) and 18F-FDG-PET/CT in patients undergoing abdominoperineal resection (APR) and its impact on oncologic outcome. A retrospective analysis of six consecutive patients who underwent APR due to primary ARMM was performed. Patients were staged by CT and PET/CT. Four out of six patients had preoperative LNM involvement (two patients inguinal and perirectal, one iliacal, one perirectal), with two of them presenting with distant metastases additionally. Inguinal/iliacal LNM in two patients as well as liver metastasis in one patient was seen in PET/CT and missed by CT. The three patients with initial inguinal/iliacal LNM died during the observation period (overall survival: 10 (6–18) months). The three patients without inguinal/iliacal LNM involvement are currently alive, one patient showing a slowly progressive disease since 5 years, and two patients are tumor-free since 8.5 and 1.5 years (the patients had initial perirectal LNM). In ARMM, PET/CT is superior to CT in detection of LNM and distant metastasis. APR is possibly a curative approach if the PET/CT shows exclusively perirectal LNM despite locally advanced tumor growth.
- 15 July 2016
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 1-9
Open AccessAnorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT
Anorectal malignant melanomas (ARMM) are rare tumors, characterized by an early lymphatic spread and distant metastasis, resulting in an extremely poor overall survival. The objective of this study was to determine the pattern of regional lymph node metastasis (LNM) by computed tomography (CT) and 18F-FDG-PET/CT in patients undergoing abdominoperineal resection (APR) and its impact on oncologic outcome. A retrospective analysis of six consecutive patients who underwent APR due to primary ARMM was performed. Patients were staged by CT and PET/CT. Four out of six patients had preoperative LNM involvement (two patients inguinal and perirectal, one iliacal, one perirectal), with two of them presenting with distant metastases additionally. Inguinal/iliacal LNM in two patients as well as liver metastasis in one patient was seen in PET/CT and missed by CT. The three patients with initial inguinal/iliacal LNM died during the observation period (overall survival: 10 (6–18) months). The three patients without inguinal/iliacal LNM involvement are currently alive, one patient showing a slowly progressive disease since 5 years, and two patients are tumor-free since 8.5 and 1.5 years (the patients had initial perirectal LNM). In ARMM, PET/CT is superior to CT in detection of LNM and distant metastasis. APR is possibly a curative approach if the PET/CT shows exclusively perirectal LNM despite locally advanced tumor growth.
- Open Access
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 70
Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 70
Open AccessCardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis
- 15 September 2015
- Published by Springer Nature in European Radiology
- Vol. 26 (6) , 1826-1834
Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study
Melanomas arising from mucosa are rare and associated with a poor prognosis. This study aims to provide an analysis of metastatic pathways, time intervals, factors influencing metastatic spread and organs for distant metastases. A total of 116 patients with mucosal melanomas of different sites were included. The mean follow-up interval was 47 ± 52 months. Patients were assigned to two different metastatic pathways, either presenting loco-regional lymph node metastases as first spread or direct distant metastases. The distribution of distant metastases was assessed. Twenty-six patients presented with a pre-existing metastatic spread and were not assigned to pathways. Of the included patients, 44 developed metastases after treatment of the primary tumour; 25 patients directly developed distant metastases; 16 patients developed regional lymph node metastases prior to distant metastases. Location of the primary tumour in the upper airway or GI tract and advanced T stage were significant risk factors of direct distant metastases. Distant metastases are mainly located in the lung, the liver and non-regional lymph nodes. Mucosal melanomas show a high rate of direct distant metastases rather than regional lymph node metastases. Thus the follow-up should always include a whole-body cross-sectional imaging in high-risk tumours. • Mucosal melanomas show a high rate of direct distant metastases. • T stage and primary location are predictors for direct distant metastases. • Distant metastases were mainly found in lung, liver and lymph nodes. • Follow-up of a high-risk mucosal melanoma should include whole-body imaging.
- 15 September 2015
- Published by Springer Nature in European Radiology
- Vol. 26 (6) , 1826-1834
Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study
Melanomas arising from mucosa are rare and associated with a poor prognosis. This study aims to provide an analysis of metastatic pathways, time intervals, factors influencing metastatic spread and organs for distant metastases. A total of 116 patients with mucosal melanomas of different sites were included. The mean follow-up interval was 47 ± 52 months. Patients were assigned to two different metastatic pathways, either presenting loco-regional lymph node metastases as first spread or direct distant metastases. The distribution of distant metastases was assessed. Twenty-six patients presented with a pre-existing metastatic spread and were not assigned to pathways. Of the included patients, 44 developed metastases after treatment of the primary tumour; 25 patients directly developed distant metastases; 16 patients developed regional lymph node metastases prior to distant metastases. Location of the primary tumour in the upper airway or GI tract and advanced T stage were significant risk factors of direct distant metastases. Distant metastases are mainly located in the lung, the liver and non-regional lymph nodes. Mucosal melanomas show a high rate of direct distant metastases rather than regional lymph node metastases. Thus the follow-up should always include a whole-body cross-sectional imaging in high-risk tumours. • Mucosal melanomas show a high rate of direct distant metastases. • T stage and primary location are predictors for direct distant metastases. • Distant metastases were mainly found in lung, liver and lymph nodes. • Follow-up of a high-risk mucosal melanoma should include whole-body imaging.
- 1 February 2015
- Published by SAGE Publications in Acta Radiologica
- Vol. 56 (2) , 143-151
Is the diagnostic yield of myocardial stress perfusion MRI impaired by three-vessel coronary artery disease?
Background: Three-vessel coronary artery disease (CAD) comes along with globally reduced myocardial perfusion potentially restricting the demarcation of regional hypoperfusion in stress perfusion cardiac magnetic resonance imaging (MRI). Purpose: To evaluate whether stress perfusion cardiac MRI is capable of detecting myocardial hypoperfusion in patients with 3-vessel CAD reliably. Material and Methods: Two hundred and five patients with symptoms of CAD were included. The examination protocol comprised imaging of myocardial perfusion at stress (0.14 mg/kg/min adenosine for 4 min) using a 2D saturation recovery gradient echo sequence after administration of gadobutrol (0.1 mmol/kg body weight). Perfusion sequences were assessed qualitatively by two experienced observers. Coronary angiography served as standard of reference. Results: Sensitivity and specificity for hemodynamically relevant stenoses in patients with 0-, 1-, 2-, 3-vessel coronary artery disease were 100%/91%, 91%/73%, 90%/71%, 92%/64%; positive/negative predictive value, 67%/100%, 91%/73%, 83%/81%, 93%/58%; diagnostic accuracy, 93%/87%/83%/87%, respectively. The negative predictive value in patients with 3-vessel CAD was lower than in patients with 0- and 2-vessel CAD and the specificity lower than in patients with no CAD whereas the positive predictive value was higher than in patients with no CAD. The other proportions did not differ significantly between the groups. Conclusion: The diagnostic value of stress perfusion cardiac MRI in patients with 3-vessel CAD is comparable to results in patients with 1- or 2-vessel CAD. In the rare event that stress perfusion images do not depict regional hypoperfusion in patients with severe 3-vessel CAD, myocardial ischemia could be identified by reduced semi-quantitative perfusion parameters.
- 1 February 2015
- Published by SAGE Publications in Acta Radiologica
- Vol. 56 (2) , 143-151
Is the diagnostic yield of myocardial stress perfusion MRI impaired by three-vessel coronary artery disease?
Background: Three-vessel coronary artery disease (CAD) comes along with globally reduced myocardial perfusion potentially restricting the demarcation of regional hypoperfusion in stress perfusion cardiac magnetic resonance imaging (MRI). Purpose: To evaluate whether stress perfusion cardiac MRI is capable of detecting myocardial hypoperfusion in patients with 3-vessel CAD reliably. Material and Methods: Two hundred and five patients with symptoms of CAD were included. The examination protocol comprised imaging of myocardial perfusion at stress (0.14 mg/kg/min adenosine for 4 min) using a 2D saturation recovery gradient echo sequence after administration of gadobutrol (0.1 mmol/kg body weight). Perfusion sequences were assessed qualitatively by two experienced observers. Coronary angiography served as standard of reference. Results: Sensitivity and specificity for hemodynamically relevant stenoses in patients with 0-, 1-, 2-, 3-vessel coronary artery disease were 100%/91%, 91%/73%, 90%/71%, 92%/64%; positive/negative predictive value, 67%/100%, 91%/73%, 83%/81%, 93%/58%; diagnostic accuracy, 93%/87%/83%/87%, respectively. The negative predictive value in patients with 3-vessel CAD was lower than in patients with 0- and 2-vessel CAD and the specificity lower than in patients with no CAD whereas the positive predictive value was higher than in patients with no CAD. The other proportions did not differ significantly between the groups. Conclusion: The diagnostic value of stress perfusion cardiac MRI in patients with 3-vessel CAD is comparable to results in patients with 1- or 2-vessel CAD. In the rare event that stress perfusion images do not depict regional hypoperfusion in patients with severe 3-vessel CAD, myocardial ischemia could be identified by reduced semi-quantitative perfusion parameters.
- 1 July 2013
- Published by Elsevier in European Journal of Radiology
- Vol. 82 (10) , 1776-1782
Is myocardial stress perfusion MR-imaging suitable to predict the long term clinical outcome after revascularization?
- 1 July 2013
- Published by Elsevier in European Journal of Radiology
- Vol. 82 (10) , 1776-1782
Is myocardial stress perfusion MR-imaging suitable to predict the long term clinical outcome after revascularization?
- Open Access
- 1 January 2013
- Published by E-MED LTD in Cancer Imaging
- Vol. 13 (4) , 540-7
Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.
In patients with peritoneal carcinomatosis, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an evolving approach with curative intention. Previous studies indicate a correlation between preoperative magnetic resonance imaging (MRI) and surgical findings regarding the extent of peritoneal carcinomatosis. The aim of this study was to assess retrospectively whether preoperative MRI can predict the outcome and is therefore a suitable tool for patient selection. Fifteen patients with laparoscopically proven peritoneal carcinomatosis were preoperatively examined using a 1.5-T whole-body MRI system. Results were correlated with surgical exploration. Follow-up was done by contrast-enhanced abdominal computed tomography and, if suspicious for recurring disease, laparoscopy or laparotomy. Survival time and interval to recurring disease were correlated with the preoperative peritoneal carcinomatosis index (PCI) on MRI (Spearman's rank correlation). In five patients radical resection could not be achieved (PCI 34 ± 6.9); survival time was 78.2 ± 54.1 days. In seven patients recurring disease was found 430 ± 261.2 days after initial complete cytoreduction (PCI 11.6 ± 6.9); survival time was 765.9 ± 355 days. Two patients are still alive after 3 years. Two patients with initially complete cytoreduction are without recurring disease after 3 years (PCI 5 and 12). One patient was lost for follow-up. Results of the preoperative MRI correlate well with the surgical PCI, postoperative resection status, and survival time. MRI might be a suitable technique for patient selection when considering peritonectomy and HIPEC. In our patients the outcome seems to correlate well with the extent of peritoneal carcinomatosis found by the preoperative MRI.
- 1 January 2013
- Published by E-MED LTD in Cancer Imaging
- Vol. 13 (4) , 540-7
Open AccessCorrelation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.
In patients with peritoneal carcinomatosis, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an evolving approach with curative intention. Previous studies indicate a correlation between preoperative magnetic resonance imaging (MRI) and surgical findings regarding the extent of peritoneal carcinomatosis. The aim of this study was to assess retrospectively whether preoperative MRI can predict the outcome and is therefore a suitable tool for patient selection. Fifteen patients with laparoscopically proven peritoneal carcinomatosis were preoperatively examined using a 1.5-T whole-body MRI system. Results were correlated with surgical exploration. Follow-up was done by contrast-enhanced abdominal computed tomography and, if suspicious for recurring disease, laparoscopy or laparotomy. Survival time and interval to recurring disease were correlated with the preoperative peritoneal carcinomatosis index (PCI) on MRI (Spearman's rank correlation). In five patients radical resection could not be achieved (PCI 34 ± 6.9); survival time was 78.2 ± 54.1 days. In seven patients recurring disease was found 430 ± 261.2 days after initial complete cytoreduction (PCI 11.6 ± 6.9); survival time was 765.9 ± 355 days. Two patients are still alive after 3 years. Two patients with initially complete cytoreduction are without recurring disease after 3 years (PCI 5 and 12). One patient was lost for follow-up. Results of the preoperative MRI correlate well with the surgical PCI, postoperative resection status, and survival time. MRI might be a suitable technique for patient selection when considering peritonectomy and HIPEC. In our patients the outcome seems to correlate well with the extent of peritoneal carcinomatosis found by the preoperative MRI.